News
New management team in Axelar AB
15 August 2018
The Board of Axelar AB has appointed Vidar Wendel-Hansen as new Chief Executive Officer at the Annual Meeting on June 20th. Dr Wendel-Hansen holds an MD, PhD from Karolinska Institutet and has more than twenty years’ experience from the life science …
Clinical Trial Application for Phase I trial of AXL1717 new capsule formulation submitted in India
9 January 2018
Since 2015 Axelar AB has had a co-development agreement with Cadila Pharmaceuticals Ltd for collaboration on AXL1717 formulation development and clinical development. Cadila Pharmaceuticals Ltd has developed a new AXL1717 formulation in 25 & 50 …